Table 1.
Sirolimus group (n = 19) | Tacrolimus group (n = 78) | p-Value | |
---|---|---|---|
African American n (%) | 1 (5.3%) | 5 (6.4%) | 0.88 |
Mean age (years) (95% CI) | 60.0 (56.2–62.5) | 57.9 (58.2–60.9) | 0.21 |
Mean BMI (95% CI) | 25.3 (22.7–27.5) | 25.6 (24.3–26.1) | 0.88 |
Mean posttransplant serum Cr level (mg/dL) (95% CI) | 1.8 (1.5–2.0) | 1.6 (1.5–1.7) | 0.22 |
Mean pretransplant PSA (ng/mL) (95% CI) | 1.8 (1.3–2.2) | 1.7 (1.5–1.9) | 0.89 |
Mean posttransplant PSA (ng/mL) (95% CI) | 0.9 (0.7–1.2) | 1.9 (1.7–2.1) | <0.001 |
CI = confidence interval; BMI = body mass index; PSA = prostate-specific antigen.